These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 29440439)
1. Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis. Meng H; Liu Z; Li X; Wang H; Jin T; Wu G; Shan B; Christofferson DE; Qi C; Yu Q; Li Y; Yuan J Proc Natl Acad Sci U S A; 2018 Feb; 115(9):E2001-E2009. PubMed ID: 29440439 [TBL] [Abstract][Full Text] [Related]
2. Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners. Li X; Zhang M; Huang X; Liang W; Li G; Lu X; Li Y; Pan H; Shi L; Zhu H; Qian L; Shan B; Yuan J Nat Commun; 2020 Dec; 11(1):6364. PubMed ID: 33311474 [TBL] [Abstract][Full Text] [Related]
3. K45A mutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo. Shutinoski B; Alturki NA; Rijal D; Bertin J; Gough PJ; Schlossmacher MG; Sad S Cell Death Differ; 2016 Oct; 23(10):1628-37. PubMed ID: 27258786 [TBL] [Abstract][Full Text] [Related]
5. The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation. Imai T; Lin J; Kaya GG; Ju E; Kondylis V; Kelepouras K; Liccardi G; Kim C; Pasparakis M Immunity; 2024 Jul; 57(7):1497-1513.e6. PubMed ID: 38744293 [TBL] [Abstract][Full Text] [Related]
6. Kinase domain dimerization drives RIPK3-dependent necroptosis. Raju S; Whalen DM; Mengistu M; Swanson C; Quinn JG; Taylor SS; Webster JD; Newton K; Shaw AS Sci Signal; 2018 Aug; 11(544):. PubMed ID: 30131368 [TBL] [Abstract][Full Text] [Related]
7. Critical contribution of oxidative stress to TNFα-induced necroptosis downstream of RIPK1 activation. Shindo R; Kakehashi H; Okumura K; Kumagai Y; Nakano H Biochem Biophys Res Commun; 2013 Jun; 436(2):212-6. PubMed ID: 23727581 [TBL] [Abstract][Full Text] [Related]
8. Necroptosis promotes cell-autonomous activation of proinflammatory cytokine gene expression. Zhu K; Liang W; Ma Z; Xu D; Cao S; Lu X; Liu N; Shan B; Qian L; Yuan J Cell Death Dis; 2018 May; 9(5):500. PubMed ID: 29703889 [TBL] [Abstract][Full Text] [Related]
9. RIPK1 inhibits ZBP1-driven necroptosis during development. Newton K; Wickliffe KE; Maltzman A; Dugger DL; Strasser A; Pham VC; Lill JR; Roose-Girma M; Warming S; Solon M; Ngu H; Webster JD; Dixit VM Nature; 2016 Dec; 540(7631):129-133. PubMed ID: 27819682 [TBL] [Abstract][Full Text] [Related]
10. NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling. Dondelinger Y; Jouan-Lanhouet S; Divert T; Theatre E; Bertin J; Gough PJ; Giansanti P; Heck AJ; Dejardin E; Vandenabeele P; Bertrand MJ Mol Cell; 2015 Oct; 60(1):63-76. PubMed ID: 26344099 [TBL] [Abstract][Full Text] [Related]
12. StIKKing it to a death kinase: IKKs prevent TNF-α-induced cell death by phosphorylating RIPK1. Dillon CP; Balachandran S Cytokine; 2016 Feb; 78():47-50. PubMed ID: 26630177 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB. Suda J; Dara L; Yang L; Aghajan M; Song Y; Kaplowitz N; Liu ZX J Immunol; 2016 Oct; 197(8):3120-3129. PubMed ID: 27605011 [TBL] [Abstract][Full Text] [Related]
14. Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis. Le Cann F; Delehouzé C; Leverrier-Penna S; Filliol A; Comte A; Delalande O; Desban N; Baratte B; Gallais I; Piquet-Pellorce C; Faurez F; Bonnet M; Mettey Y; Goekjian P; Samson M; Vandenabeele P; Bach S; Dimanche-Boitrel MT FEBS J; 2017 Sep; 284(18):3050-3068. PubMed ID: 28715128 [TBL] [Abstract][Full Text] [Related]
15. Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis. Amin P; Florez M; Najafov A; Pan H; Geng J; Ofengeim D; Dziedzic SA; Wang H; Barrett VJ; Ito Y; LaVoie MJ; Yuan J Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E5944-E5953. PubMed ID: 29891719 [TBL] [Abstract][Full Text] [Related]
16. Necroptosis in development and diseases. Shan B; Pan H; Najafov A; Yuan J Genes Dev; 2018 Mar; 32(5-6):327-340. PubMed ID: 29593066 [TBL] [Abstract][Full Text] [Related]
17. Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation. Laurien L; Nagata M; Schünke H; Delanghe T; Wiederstein JL; Kumari S; Schwarzer R; Corona T; Krüger M; Bertrand MJM; Kondylis V; Pasparakis M Nat Commun; 2020 Apr; 11(1):1747. PubMed ID: 32269263 [TBL] [Abstract][Full Text] [Related]
18. MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death. Jaco I; Annibaldi A; Lalaoui N; Wilson R; Tenev T; Laurien L; Kim C; Jamal K; Wicky John S; Liccardi G; Chau D; Murphy JM; Brumatti G; Feltham R; Pasparakis M; Silke J; Meier P Mol Cell; 2017 Jun; 66(5):698-710.e5. PubMed ID: 28506461 [TBL] [Abstract][Full Text] [Related]
19. Intermediate domain of receptor-interacting protein kinase 1 (RIPK1) determines switch between necroptosis and RIPK1 kinase-dependent apoptosis. Duprez L; Bertrand MJ; Vanden Berghe T; Dondelinger Y; Festjens N; Vandenabeele P J Biol Chem; 2012 Apr; 287(18):14863-72. PubMed ID: 22362767 [TBL] [Abstract][Full Text] [Related]
20. Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis. Hou J; Ju J; Zhang Z; Zhao C; Li Z; Zheng J; Sheng T; Zhang H; Hu L; Yu X; Zhang W; Li Y; Wu M; Ma H; Zhang X; He S Cell Death Dis; 2019 Jun; 10(7):493. PubMed ID: 31235688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]